| 序号 |
产品 |
规格 |
分类 |
批准状态 |
|
| 1 |
阿昔洛韦胶囊 |
200mg |
Antiviral |
US FDA |
|
| 2 |
阿昔洛韦片 |
400mg、800mg |
Antiviral |
US FDA |
|
| 3 |
阿那曲唑片 |
1mg |
Anticancer |
US FDA |
|
| 4 |
巴氯芬片 |
10mg、20mg |
Skeletal muscle relaxants |
US FDA |
|
| 5 |
布美他尼片 |
0.5mg、1mg、2mg |
Diuretics |
US FDA |
|
| 6 |
盐酸安非他酮缓释片 |
150mg、300mg |
Antidepressant |
US FDA |
|
| 7 |
卡马西平缓释片 |
100mg、200mg、400mg |
Anti-seizure |
US FDA |
|
| 8 |
塞来昔布胶囊 |
50mg、100mg、200mg、400mg |
Anti-inflammatory |
US FDA |
|
| 9 |
环丙沙星片 |
250mg、500mg |
Antibiotics |
US FDA |
|
| 10 |
非洛地平缓释片 |
2.5mg、5mg、10mg |
Cardiovascular |
US FDA |
|
| 11 |
厄贝沙坦片 |
75mg、150mg、300mg |
Cardiovascular |
US FDA |
|
| 12 |
拉莫三嗪缓释片 |
25mg、50mg、100mg、 200mg、250mg、300mg |
Antiepileptic |
US FDA |
|
| 13 |
来曲唑片 |
2.5mg |
Anticancer |
US FDA |
|
| 14 |
利多卡因注射液 |
1%、2%、4% |
Anesthetic |
US FDA |
|
| 15 |
孟鲁司特钠咀嚼片 |
4mg、5mg |
Anti-inflammatory |
US FDA |
|
| 16 |
孟鲁司特钠片 |
10 mg |
Anti-inflammatory |
US FDA |
|
| 17 |
盐酸美金刚片 |
5mg、10mg |
Alzheimer's Disease |
US FDA |
|
| 18 |
盐酸米多君片 |
2.5mg、5mg、10mg |
Cardiovascular |
US FDA |
|
| 19 |
帕罗西汀片 |
10mg、20mg、30mg、40mg |
Antidepressant |
US FDA |
|
| 20 |
普瑞巴林胶囊 |
75mg、300mg |
Antiepileptic |
US FDA |
|
| 21 |
辛伐他汀片 |
10mg、20mg、40mg、80mg |
Cardiovascular |
US FDA |
|
| 22 |
盐酸坦索罗辛缓释胶囊 |
0.4 mg |
Urinary system |
US FDA |
|
| 23 |
伐昔洛韦片 |
500mg、1000mg |
Antiviral |
US FDA |
|
| 24 |
奎硫平缓释片 |
50mg、150mg、200 mg、300mg、400mg |
Schizophrenia |
Under US FDA review |
|
| 25 |
马来酸阿伐曲泊帕片 |
20mg |
Blood system |
China NMPA |
|
| 26 |
阿加曲班注射液 |
2ml: 10mg |
Cardio-cerebrovascular |
China NMPA |
|
| 27 |
阿仑膦酸钠片 |
70mg |
Osteoporosis |
China NMPA |
|
| 28 |
巴瑞替尼片 |
2mg |
Immunology |
China NMPA |
|
| 29 |
比拉斯汀片 |
20mg |
Urticaria |
China NMPA |
|
| 30 |
富马酸贝达喹啉片 |
100mg |
Antituberculosis |
China NMPA |
|
| 31 |
达泊西汀片 |
30mg |
Premature ejaculation |
China NMPA |
|
| 32 |
注射用艾司奥美拉唑钠 |
40mg |
Digestive system |
China NMPA |
|
| 33 |
恩扎卢胺软胶囊 |
40mg |
Anticancer |
China NMPA |
|
| 34 |
乙胺吡嗪利福异烟片(Ⅱ) |
Each tablet contains Rifampicin 150 mg, Isoniazid 75 mg, Pyrazinamide 400 mg and Ethambutol Hydrochloride 275 mg |
Antituberculosis |
China NMPA |
|
| 35 |
非奈利酮片 |
10mg |
Cardiovascular |
China NMPA |
|
| 36 |
非那雄胺他达拉非胶囊 |
Finasteride 5mg and Tadalafil 5mg |
Erectile dysfunction |
China NMPA |
|
| 37 |
碳酸镧咀嚼片 |
500mg |
Digestive system |
China NMPA |
|
| 38 |
孟鲁司特钠颗粒 |
4mg |
Asthma |
China NMPA |
|
| 39 |
米诺地尔搽剂 |
2% (60ml: 1.2g) 5% (60ml: 3.0g) |
Androgenetic alopecia and alopecia areata |
China NMPA |
|
| 40 |
马昔腾坦片 |
10mg |
Pulmonary Arterial Hypertension |
China NMPA |
|
| 41 |
甲巯咪唑片 |
5mg、10mg |
Hyperthyroidism |
China NMPA |
|
| 42 |
尼莫地平注射液 |
50ml:10mg |
Cardiovascular |
China NMPA |
|
| 43 |
乙磺酸尼达尼布软胶囊 |
100mg、150mg |
Respiratory |
China NMPA |
|
| 44 |
奥硝唑注射液 |
3ml: 0.5g |
Antibacterial |
China NMPA |
|
| 45 |
注射用泮托拉唑钠 |
40mg |
Digestive system |
China NMPA |
|
| 46 |
聚甲酚磺醛溶液 |
25ml(36%) |
Gynecological medication |
China NMPA |
|
| 47 |
泮托拉唑钠肠溶胶囊 |
40mg |
Digestive system |
China NMPA |
|
| 48 |
盐酸普拉克索缓释片 |
0.375mg、0.75mg |
Nervous |
China NMPA |
|
| 49 |
吡仑帕奈片 |
2mg、4mg |
Seizure |
China NMPA |
|
| 50 |
瑞戈非尼片 |
40mg |
Anticancer |
China NMPA |
|
| 51 |
酒石酸卡巴拉汀胶囊 |
1.5mg、3.0mg |
Nervous |
China NMPA |
|
| 52 |
富马酸卢帕他定片 |
10mg |
Antiallergic |
China NMPA |
|
| 53 |
利福平异烟肼片 |
300mg/150mg |
Antituberculosis |
China NMPA |
|
| 54 |
利福平胶囊 |
300mg、150mg |
Antituberculosis |
China NMPA |
|
| 55 |
枸橼酸西地那非口崩片 |
50mg |
Erectile dysfunction |
China NMPA |
|
| 56 |
枸橼酸西地那非片 |
20mg |
Pulmonary Arterial Hypertension |
China NMPA |
|
| 57 |
枸橼酸西地那非片 |
100mg |
Erectile Dysfunction |
China NMPA |
|
| 58 |
他达拉非片 |
5mg |
Erectile dysfunction |
China NMPA |
|
| 59 |
硫酸阿托品滴眼液 |
1%(0.4ml:4mg) |
Ophthalmic |
To be submitted in Mar.2025 |
|
| 60 |
布瑞哌唑片 |
0.5mg、1mg、2mg |
Schizophrenia |
Approved by China NMPA in 2026 |
|
| 61 |
复方硫酸钠片 |
Each tablet contains Sodium Sulfate 1.479 g, Magnesium Sulfate (calculated as MgSO4) 0.225 g, Potassium Chloride 0.188 g |
Digestive system |
Approved by China NMPA in 2026 |
|
| 62 |
环孢素滴眼液(Ⅲ) |
0.1%(0.3ml:0.3mg) |
Ophthalmic |
To be submitted in Apr.2025 |
|
| 63 |
环孢素滴眼液(II) |
0.05%(0.4ml:0.2mg) |
Ophthalmic |
Submitted to US FDA in Jan.2024 |
|
| 64 |
地夸磷索钠滴眼液 |
3%(5ml:150mg) |
Dry Eye Disease |
Approved by China NMPA in 2026 |
|
| 65 |
地诺孕素片 |
2mg |
Contraceptives |
Approved by China NMPA in 2027 |
|
| 66 |
硫酸氨基葡萄糖胶囊 |
0.25 g (calculated as glucosamine sulfate) or 0.314 g (calculated as glucosamine sulfate sodium chloride salt) |
Osteoarthritis |
Approved by China NMPA in 2027 |
|
| 67 |
吲哚布芬片 |
0.2g |
thromboembolic diseases |
Approved by China NMPA in 2027 |
|
| 68 |
盐酸拉贝洛尔片 |
100mg、200mg |
Cardiovascular |
Approved by China NMPA in 2026 |
|
| 69 |
利多卡因丙胺卡因气雾剂 |
Each bottle contains 110 actuations. Each actuation delivers 7.5 mg lidocaine and 2.5 mg prilocaine |
Primary premature ejaculation in adult males |
Approved by China NMPA in 2027 |
|
| 70 |
利丙双卡因乳膏 |
5 g: Lidocaine 125 mg and Prilocaine 125 mg |
Local anesthetic |
To be submitted in Apr.2025 |
|
| 71 |
蒙脱石混悬液 |
3g、10g |
Gastrointestinal |
Approved by China NMPA in 2026 |
|
| 72 |
美沙拉秦缓释胶囊 |
375mg |
Digestive system |
Submitted to US FDA in Feb.2023 |
|
| 73 |
聚多卡醇注射液 |
2ml:20mg |
Varicose Veins |
Approved by China NMPA in 2026 |
|
| 74 |
盐酸毛果芸香碱滴眼液 |
1.25%(2.5ml:31.25mg) |
Ophthalmic |
Approved by China NMPA in 2027 |
|
| 75 |
普托马尼片 |
200mg |
Antituberculosis |
Approved by China NMPA in 2028 |
|
| 76 |
利福昔明片 |
200mg、550mg |
Antibacterial |
To be submitted in Q4.2025 |
|
| 77 |
甲磺酸沙非胺片 |
50mg、100mg |
Parkinson's disease |
Approved by China NMPA in 2027 |
|
| 78 |
布地奈德肠溶胶囊 |
4mg |
Gastrointestinal anti-inflammatory |
R&D |
|
| 79 |
柑橘黄酮片 |
0.5g |
Cardiovascular |
R&D |
|
| 80 |
注射用顺铂聚合物胶束 |
50mg |
Anticancer |
R&D |
|
| 81 |
双氯酚酸钠双释放肠溶胶囊 |
100mg、75mg |
Anti-inflammatory |
R&D |
|
| 82 |
格列齐特片II |
80mg |
Diabetes |
R&D |
|
| 83 |
依柯胰岛素 |
700 IU/mL |
diabetes |
R&D |
|
| 84 |
碳酸锂缓释片 |
300mg |
Psychiatric |
R&D |
|
| 85 |
硫酸吗啡缓释片 |
10mg、30mg、60mg |
Analgesic |
R&D |
|
| 86 |
硝呋太尔制霉菌素阴道软胶囊 |
0.5 g × 20,000 Units |
Vaginitis |
R&D |
|
| 87 |
盐酸普萘洛尔缓释胶囊 |
60mg、80mg |
Cardiovascular |
R&D |
|
| 88 |
注射用紫杉醇聚合物胶束 |
30mg |
Anticancer |
R&D |
|
| 89 |
罗普司亭 |
250g |
Blood system |
R&D |
|
| 90 |
注射用紫杉醇(白蛋白结合型) |
100mg |
Anticancer |
TBD |
|